Pfizer says three drugs in Phase III trials for deadly cancers

06/5/2007 | Forbes

Pfizer says three of its cancer drugs are set to undergo large-scale Phase III trials for several deadly cancers, one of them for an extended indication. The firm said its Sutent for stomach and kidney cancers is being tested for liver cancer, its Axitinib for pancreatic cancer, and its CP-751,871 compound for non-small-cell lung cancer.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY